Eliminating METTL1‐mediated accumulation of PMN‐MDSCs prevents hepatocellular carcinoma recurrence after radiofrequency ablationXuezhen Zeng, Yi Zhao, Xuxin Ren et al.|Hepatology|2022Cited by 164
Targeting tumour-intrinsic N <sup>7</sup> -methylguanosine tRNA modification inhibits MDSC recruitment and improves anti-PD-1 efficacyHai‐Ning Liu, Shuibin Lin, Xuezhen Zeng et al.|Gut|2022Cited by 79
Combination Neoantigen-Based Dendritic Cell Vaccination and Adoptive T-Cell Transfer Induces Antitumor Responses Against Recurrence of Hepatocellular CarcinomaSui Peng, Ming Kuang, Shuling Chen et al.|Cancer Immunology Research|2022Cited by 72
Distinct single-cell immune ecosystems distinguish true and de novo HBV-related hepatocellular carcinoma recurrencesShuling Chen, Ming Kuang, Cheng Huang et al.|Gut|2023Cited by 66
A novel cuproptosis-related prognostic gene signature and validation of differential expression in hepatocellular carcinomaYaoting Li, Xuezhen Zeng|Frontiers in Pharmacology|2023Cited by 20